Genomics

Dataset Information

Comprehensive target engagement by EZH2 inhibitor CPI-0209 allows for preferential targeting of ARID1A mutant urothelial carcinoma


ABSTRACT: Comprehensive target engagement by EZH2 inhibitor CPI-0209 allows for preferential targeting of ARID1A mutant urothelial carcinoma

PROVIDER: PRJNA736424 | ENA |

REPOSITORIES: ENA